Reviewing Schrodinger (NASDAQ:SDGR) & Health In Tech (NASDAQ:HIT)

Health In Tech (NASDAQ:HIT) and Schrodinger (NASDAQ:SDGR) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, profitability, institutional ownership, risk, dividends, valuation and earnings.

Profitability

This table compares Health In Tech and Schrodinger’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Health In Tech	N/A	N/A	N/A
Schrodinger	-22.02%	-17.66%	-8.89%

Earnings and Valuation

This table compares Health In Tech and Schrodinger”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Health In Tech	$32.83 million	1.15	-$4.59 million	($0.07)	-8.23
Schrodinger	$255.87 million	8.30	-$103.26 million	($0.79)	-36.42

Health In Tech has higher earnings, but lower revenue than Schrodinger. Schrodinger is trading at a lower price-to-earnings ratio than Health In Tech, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for Health In Tech and Schrodinger, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Health In Tech	1	0	1	1	2.67
Schrodinger	1	3	4	0	2.38

Health In Tech currently has a consensus price target of $3.50, suggesting a potential upside of 507.22%. Schrodinger has a consensus price target of $26.67, suggesting a potential downside of 7.31%. Given Health In Tech’s stronger consensus rating and higher probable upside, analysts plainly believe Health In Tech is more favorable than Schrodinger.

Volatility & Risk

Health In Tech has a beta of 3.02, suggesting that its share price is 202% more volatile than the S&P 500. Comparatively, Schrodinger has a beta of 1.69, suggesting that its share price is 69% more volatile than the S&P 500.

Institutional & Insider Ownership

79.0% of Schrodinger shares are owned by institutional investors. 71.0% of Health In Tech shares are owned by insiders. Comparatively, 10.1% of Schrodinger shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

Health In Tech beats Schrodinger on 11 of the 15 factors compared between the two stocks.

About Health In Tech

Health in Tech, Inc. engages in the provision of insurance technology platforms which offer a marketplace of processes in the healthcare industry. Its services include Stone Mountain Risk, eDIYBS, HI Card, HI Performance Network, and Ancillary Products. The company was founded by Tim Johnson in 2014 and is headquartered in Stuart, FL.

About Schrodinger

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.